Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 309-313

  Bolger, B S ^a   Dabbas, M ^a   Lopes, A ^a   Monaghan, J M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0031148789     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4619     Document Type: Article

References (14)

1. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 40:1977;1621-1628.
2. Crombach G, Scharl A, Vierbuchen M, Wurz H, Bolte A. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer. 63:1989;1337-1342.
3. Duk J M, de Bruijn H W, Groenier K H, Hollema H, ten Hoor K A, Krans M, Aalders J G. Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol. 39:1990;186-194.
4. Schmidt-Rhode P, Schulz K D, Sturm G, Hafner H, Prinz H, Kunzig H J. Squamous cell carcinoma antigen for monitoring cervical cancer. Int J Biol Markers. 3:1988;87-94.
5. Patsner B, Orr J Jr, Allmen T. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix? Obstet Gynecol. 74:1989;786-788.
6. Yazigi R, Munoz A K, Richardson B, Risser R. Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer. Gynecol Oncol. 41:1991;135-138.
7. Avall-Lundqvist E H, Sjovall K, Nilsson B R, Eneroth P H. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer. 10:1992;1695-1702.
8. Bolli J A, Doering D L, Bosscher J R, Day T Jr, Rao C V, Owens K, Kelly B, Goldsmith J. Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 55:1994;169-173.
9. Gaarenstroom K N, Kenter G G, Bonfrer J M, Korse C M, Gallee M P, Hart A A, Muller M, Trimbos J B, Helmerhorst T J. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer. Cancer. 74:1994;2307-2313.
10. Ngan H Y, Cheng G T, Yeung W S, Wong L C, Ma H K. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Gynecol Oncol. 52:1994;63-68.
11. Beynon D WG, Lopes A, Robertson G, Daras V, Monaghan J M. Squamous cell carcinoma antigen: pretreatment levels as an indicator of advanced or metastatic disease. Int J Gynaecol Cancer. 4:1994;206-210.
12. Holloway R W, To A, Moradi M, Boots L, Watson N, Shingleton H M. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay [see comments]. Obstet Gynecol. 74:1989;944-949.
13. H, Shingleton, J, Orr, 1995, Cancer of the Cervix, Lippincott, Philadelphia.
14. Bandy L, Clarke-Pearson D, Silverman P, Creasman W. Computerised tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynaecol. 65:1985;73-76.